Cargando…
Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?
Dendritic cells (DC) have been tested in cancer immunotherapy clinical trials for two decades. Over this time, the methods of DC culture (or manufacture) have evolved, the approaches for antigen loading have broadened, the maturation signals have varied and different sites of administration have bee...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861778/ https://www.ncbi.nlm.nih.gov/pubmed/24379816 http://dx.doi.org/10.3389/fimmu.2013.00454 |